Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial.
about
Strategies for developing novel therapeutics for sensorineural hearing loss.Steroids for idiopathic sudden sensorineural hearing loss[Local drug therapy for inner ear hearing loss].Application of insulin-like growth factor-1 in the treatment of inner ear disordersGrowth factor-eluting cochlear implant electrode: impact on residual auditory function, insertional trauma, and fibrosis.Corticosteroid therapy for hearing and balance disordersThe Transcriptomics to Proteomics of Hair Cell Regeneration: Looking for a Hair Cell in a HaystackBrain-derived neurotrophic factor modulates auditory function in the hearing cochlea.Intracochlear drug delivery systems.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.The role of insulin-like growth factor-I in the physiopathology of hearing.A novel chitosan-hydrogel-based nanoparticle delivery system for local inner ear application.The minimum peptides of IGF-1 and substance P protect vestibular hair cells against neomycin ototoxicity.Reservoir-based polymer drug delivery systems.Nanomedicine strategies for drug delivery to the ear.How controlled release technology can aid gene delivery.Biological therapies in otology.Growth factors released from gelatin hydrogel microspheres increase new neurons in the adult mouse brain.Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-β1 (TGF-β1) administration suppresses osteoblast differentiationThe Effect of Insulin Like Growth Factor-1 on Recovery of Facial Nerve Crush Injury.The effect of local application of insulin-like growth factor for prevention of inner-ear damage caused by electrode trauma.IGF-1 deficiency causes atrophic changes associated with upregulation of VGluT1 and downregulation of MEF2 transcription factors in the mouse cochlear nuclei.[Biological therapies in otology. German version].A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus).
P2860
Q21129270-C6F8B793-253A-4B35-8CE5-62B8193AFD88Q24201365-C3423585-2454-4B8B-9BD9-6E947DB88F5AQ30317246-82AB8960-0DEF-4E19-883C-5817A1460F95Q30428706-0F901F3A-620F-41E7-B946-60C4A3C31833Q30428825-76BE2097-0BFC-4896-BE49-0CE4EF9BE6B9Q30439597-CC974027-5119-471D-A797-3658053A2C34Q30444614-2357AE77-8918-4341-9B78-903732E9963EQ30458638-B83E0081-5C82-4294-9D66-BA962BA83F28Q30464082-3E4BC4CF-C665-4326-B3FE-7AB04C3BC803Q33882297-17F000CC-208D-4837-A508-7260A272F872Q34537290-5EA942DB-9DE5-4EB5-AD26-51BB39A1A680Q35135142-6DD60431-77A3-4659-8201-B7789CE1A30BQ35193795-8C1D1D81-D2B3-4E6A-9D91-D027EF66A51BQ35571686-E0763349-BF0A-4E67-9FAF-71D502F6C5C8Q37987369-0DC57D77-01D6-47FC-A2F9-3F4A08549458Q38120319-47D6A482-4F55-47C8-826C-96458C0862B8Q38539596-7928BBFC-3DF4-4EDB-9970-49FDC9D83F59Q39206268-9E58A369-BD32-47E0-8457-155CB83D6C0BQ41777840-B10D382D-684A-45B0-8E98-188259E56F77Q42036660-7E3016A7-66ED-4E71-87BD-B9855EDF3F3AQ45017539-A847F5D5-94ED-42DF-87EF-BE0C5A6511F5Q48338993-370547F4-F2E4-4DA4-B8E6-11485EFEBC13Q48462977-6D35A622-45C1-45AE-8004-CFBDDE6C4AF6Q50311608-683BD65F-35F3-4BE4-B247-9642DE0CF9DEQ52649043-8B1A2EDD-016A-4F6E-A106-5729773E7C43
P2860
Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Topical insulin-like growth fa ...... a prospective clinical trial.
@ast
Topical insulin-like growth fa ...... a prospective clinical trial.
@en
type
label
Topical insulin-like growth fa ...... a prospective clinical trial.
@ast
Topical insulin-like growth fa ...... a prospective clinical trial.
@en
prefLabel
Topical insulin-like growth fa ...... a prospective clinical trial.
@ast
Topical insulin-like growth fa ...... a prospective clinical trial.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Topical insulin-like growth fa ...... : a prospective clinical trial
@en
P2093
Harue Tada
Harukazu Hiraumi
Juichi Ito
Kazuya Ono
Ken-ichi Inui
Kiyomi Hamaguchi
Masaya Yamamoto
Norio Yamamoto
Rie Onodera
Shiro Tanaka
P2860
P2888
P356
10.1186/1741-7015-8-76
P407
P577
2010-11-25T00:00:00Z
P5875
P6179
1009661441